NRBO
NeuroBo Pharmaceuticals Inc
Halal Rating :
Last Price
$9.00
Last updated:
Market Cap
-
7D Change
6.81%
1 Year Change
412.24%
Company Overview
Industries
Exchange
Next Earnings Date
NeuroBo Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing novel treatments for neurodegenerative diseases and cardiometabolic disorders. The company's primary focus is on advancing therapeutic candidates that target the treatment of obesity and diabetes.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|
Company Impact
Help us evaluate NeuroBo Pharmaceuticals Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.